+91 22 24172311
Sections
Search
Subscribe
Equity
Venture Capital
Private Equity
M&A
Private Equity | 23 April 2012

Intas Pharma To Raise R250Cr From PE Funds For Expansion

by Irfan Khan
 
@irfan

Intas Pharma is planning to raise R250Cr private equity investment for expansion.

PE investors - ChrysCapital, Blackstone, Advent Capital among others are in talks to buy minority stake in the company.

Last March, Intas Pharma filed DRHP to raise upto R425Cr through fresh issue of shares, while ChrysCapital was planning to part-exit in the IPO by selling 58,10,550 shares.

The company intends to use the funds raised through fresh issue for product registration (R108.5Cr), capital expenditure (R218.75Cr) and for other corporate purposes.

Intas has planned its IPO for this year and is re-examining its timing due to market volatility.


In 2005, ChrysCapital had bought 12.47% stake for a total consideration of R53Cr and after bonus issues by the company, its stake stands at 11.2% at an average price of R45.60 per share.

Ibibo.com's Parent Co - MIH Group Acquires Tek Travels

MIH Group has acquired 51% stake in Gurgoan based Tek Travels Private Limited, which owns B2B travel portal Travel Boutique Online.

Read More...

GE Energy Invests In Atria's Wind Power Projects

GE Energy Financial Services has invested an undisclosed amount picking up equity stake in three wind power projects being developed by Atria Power Corporation Limited.

Read More...
TL Home Search New Keet
CONTACT US
Info@DealCurry.com
+91 22 24172311
A 311, 3rd Floor, AntopHill Warehousing Company,
Near Dosti Acres
Wadala(E),
Mumbai 400037
   
 
CLIENTS
USEFUL LINKS
SOLUTIONS
Copyright © EagleEye Research & Media Pvt. Ltd. 2009 All Rights Reserved - Interactive multimedia analysis platform for financial markets.
Site map |Terms of Use |Privacy Policy
DealCurry tracks financial and corporate markets for events, interprets and integrates the information in our platform, providing premium data, news and analytics. DealCurry provides comprehensive coverage of the capital markets through an intuitive, user-friendly interface.